CTT Pharma Uplists to the OTCQB Today
CTT Pharmaceutical Holdings (OTCQB:CTTH) has successfully uplisted to the OTCQB Market effective March 9, 2025, trading under the ticker symbol 'CTTH'. The company's CEO is scheduled to release a shareholder update on Wednesday, March 12, 2025.
CTT Pharmaceutical Holdings (OTCQB:CTTH) è stata promossa con successo al Mercato OTCQB a partire dal 9 marzo 2025, negoziando sotto il simbolo 'CTTH'. Il CEO dell'azienda è programmato per rilasciare un aggiornamento agli azionisti mercoledì 12 marzo 2025.
CTT Pharmaceutical Holdings (OTCQB:CTTH) ha logrado con éxito su promoción al Mercado OTCQB a partir del 9 de marzo de 2025, cotizando bajo el símbolo 'CTTH'. El CEO de la empresa tiene programado publicar una actualización para los accionistas el miércoles 12 de marzo de 2025.
CTT Pharmaceutical Holdings (OTCQB:CTTH)는 2025년 3월 9일부터 OTCQB 시장으로 성공적으로 상장되었으며, 'CTTH'라는 티커 심볼로 거래됩니다. 회사의 CEO는 2025년 3월 12일 수요일에 주주 업데이트를 발표할 예정입니다.
CTT Pharmaceutical Holdings (OTCQB:CTTH) a réussi à être promue sur le Marché OTCQB à compter du 9 mars 2025, négociant sous le symbole 'CTTH'. Le PDG de l'entreprise est prévu pour publier une mise à jour aux actionnaires le mercredi 12 mars 2025.
CTT Pharmaceutical Holdings (OTCQB:CTTH) hat erfolgreich zum OTCQB-Markt gewechselt, wirksam ab dem 9. März 2025, und wird unter dem Tickersymbol 'CTTH' gehandelt. Der CEO des Unternehmens plant, am Mittwoch, den 12. März 2025, ein Update für die Aktionäre zu veröffentlichen.
- Uplisting to OTCQB Market potentially increases visibility and liquidity for shareholders
- None.
TAMPA, FL / ACCESS Newswire / March 9, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has entered the OTCQB Market today under the ticker symbol "CTTH". CTT Pharma's CEO will issue a news release to shareholders this Wednesday March 12, 2025.
About CTT Pharmaceuticals Holdings, Inc.
CTT has patented technology in the United States, Europe, Canada and many additional countries to allow many actives on a dissolvable strip that include but are not limited to Nicotine, Vitamins, and Pharmaceuticals. CTT believes that there is a need for our technology in many industries, which includes a smoke-free nicotine strip that can be used as a smoking cessation product and delivering drugs that can help with pain management and anxiety. CTT Pharma incorporates micelle technology into its drug delivery. These strips dissolve quickly, deliver low dose options and offer better bioavailability.
CTT Pharma - 813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
FAQ
When did CTT Pharmaceutical Holdings (CTTH) uplist to OTCQB?
What is the new trading symbol for CTT Pharmaceutical Holdings on OTCQB?
When will CTT Pharmaceutical Holdings (CTTH) release its shareholder update?
What market did CTT Pharmaceutical Holdings uplist from before joining OTCQB?
